AMBU ANNOUNCES NEW CHIEF OPERATIONS OFFICER
Henrik Birk steps down from his position as Chief Operations Officer at Ambu. Former Novozymes COO, Graziela Malucelli, takes on the position, effective immediately.
Effective today, Ambu appoints Graziela Malucelli as the company’s new Chief Operations Officer (COO). She succeeds Henrik Birk who will regrettably be stepping down, due to personal circumstances, a decision made with the support of Ambu’s Executive Management.
During Henrik Birk’s time at Ambu, he has been a truly respected leader with a great impact on Ambu teams and operations worldwide. However, given Henrik’s pressing personal priorities, he and CEO Britt Meelby Jensen have collaboratively agreed that this transition serves the best interests of both Henrik and the organisation.
“I am sad to be saying goodbye to Henrik, and I extend my heartfelt gratitude to him for his positive impact on Ambu. As Graziela Malucelli steps into the COO role, I am thrilled that we have been able to secure such a highly accomplished leader. I am confident that Graziela’s dynamic leadership and extensive operational expertise will take our organisation to the next level, as she leverages her extensive capabilities and expertise in driving global operations at scale.”
BRITT MEELBY JENSEN
Chief Executive Officer
Highly experienced COO to spearhead Ambu’s global operations
Taking on the role as Chief Operations at Ambu will be Graziela Malucelli, former COO at Novozymes. At Ambu, Graziela will step into Ambu’s Executive Leadership Team, dedicated to leading Ambu’s global operations teams and ensuring efficient innovation scale-up, reliable market supply and sustainable profitable growth.
Graziela is a highly experienced operational leader, possessing 25 years of experience leading large-scale operational teams across Europe, Asia-Pacific, Latin-America and North America. During her decades-long and notable career at Novozymes, she has held several key leadership roles. In her most recent position as COO, she successfully drove profitable growth and operational excellence across more than 15 global sites, supplying customers with innovative solutions to 140 markets and leading over 3,500 team members.
Above all, she is a purpose-driven and forward-thinking leader, with a strong strategic mindset, a keen customer focus and a passion for driving transformational change. Alongside her results-oriented leadership approach, she has a proven track-record of fostering engaged and collaborative global teams, and she is excited to join Ambu to make her mark on the company’s growth journey:
“I’m honoured and excited to take on the position as COO and to get the opportunity to contribute with my experience to strengthen Ambu’s position as the leader in single-use endoscopy, in our shared efforts to save lives. Together with Britt Meelby Jensen, the Executive Leadership Team and the talented Ambu colleagues, I am looking forward to bringing innovative healthcare solutions to patients and healthcare providers around the world.”
GRAZIELA MALUCELLI
New Chief Operations Officer
Keywords
Contacts
Tine Bjørn SchmidtHead of Corporate Communications
Tel:+45 2264 0697tisc@ambu.comAnders HjortHead of Investor Relations
Tel:+45 2892 8881anhj@ambu.comDocuments
About Ambu
Since 1937, Ambu has been rethinking solutions, together with healthcare professionals, to save lives and improve patient care. Today, millions of patients and healthcare professionals worldwide depend on the efficiency, safety and performance of our single-use endoscopy, anaesthesia and patient monitoring solutions. Headquartered near Copenhagen in Denmark, Ambu employs around 4,600 people in Europe, North America, Latin America and Asia Pacific. For more information, please visit Ambu.com.
Subscribe to releases from Ambu A/S
Subscribe to all the latest releases from Ambu A/S by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Ambu A/S
AMBU LAUNCHES HD CYSTOSCOPY SOLUTION IN THE U.S.17.10.2024 16:46:40 CEST | Press release
Following the FDA clearance for the Ambu® aScope™ 5 Cysto HD solution, Ambu introduces its HD cystoscope to urologists in the USA, expanding the urology offering and meeting advanced needs for cystoscopy procedures requiring superior image quality.
AMBU OBTAINS CE MARK FOR NEW GENERATION DUODENOSCOPY SOLUTION8.8.2024 13:00:00 CEST | Press release
Having obtained both CE mark and FDA clearance, Ambu continues its controlled market release phase, focused on evaluation in key hospitals in the USA and Europe.
AMBU OBTAINS FDA CLEARANCE FOR NEW URETEROSCOPY ENDOSCOPY SOLUTION26.6.2024 14:00:00 CEST | Press release
The new clearance marks Ambu’s rapidly growing presence in urology, advancing the company’s urology portfolio in the U.S. market.
AMBU OBTAINS FDA CLEARANCE FOR NEW GENERATION DUODENOSCOPY SOLUTION19.4.2024 09:00:00 CEST | Press release
To meet the unique needs of gastroenterologists performing ERCP procedures, Ambu’s new generation aScope Duodeno 2 solution constitutes a step change from previous generations, driven by valuable collaboration with healthcare professionals.
AMBU OBTAINS FDA CLEARANCE FOR WORLD’S FIRST SINGLE-USE THERAPEUTIC GASTROSCOPE8.4.2024 14:14:26 CEST | Press release
Ambu’s aScope™ Gastro Large, with its 4.2 mm working channel and endoscope handle made with bioplastics, expands the company’s single-use portfolio for upper gastroenterology (GI) procedures. The expanded portfolio allows physicians to address an extended range of needs across the ICU, OR and endoscopy suite.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom